1
by Smith, M. E. Beth
Published 2009
Oregon Health & Science University
...HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin...

2
by Smith, M. E. Beth
Published 2009
Oregon Health & Science University
...HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin...

3
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
... were highest with amphetamine-based products but similar among methylphenidate products. Evidence...

4
by McDonagh, Marian S.
Published 2011
Oregon Health & Science University
... were highest with amphetamine-based products but similar among methylphenidate products. Evidence...

5
by Smith, Beth Paterson
Published 2010
Oregon Health & Science University
... multiple sclerosis. Evidence suggested that all 3 interferon beta-1 products and glatiramer reduced...

6
by Smith, Beth Paterson
Published 2010
Oregon Health & Science University
... multiple sclerosis. Evidence suggested that all 3 interferon beta-1 products and glatiramer reduced...

7
by Jonas, Dan
Published 2008
Oregon Health & Science University
...-IgE medications, and combination products. The purpose of this review is to compare the benefits...

8
by Jonas, Dan
Published 2008
Oregon Health & Science University
...-IgE medications, and combination products. The purpose of this review is to compare the benefits...

9
by Jonas, Dan
Published 2011
Oregon Health & Science University

10
by Jonas, Dan
Published 2011
Oregon Health & Science University

11
by Jonas, Dan
Published 2011
Oregon Health & Science University

12
by Jonas, Dan
Published 2011
Oregon Health & Science University

13
by McDonagh, Marian S.
Published 2010
Oregon Health & Science University

14
by McDonagh, Marian S.
Published 2010
Oregon Health & Science University

15
by Lin, Jennifer
Published 2011
Agency for Healthcare Research and Quality, U.S. Department for Health and Human Services
... examining indoor tanning device use and sunscreen use may not be applicable to today's products due...

16
by Norris, Susan L., Weinstein, Jessica, Peterson, Kim, Thakurta, Sujata
Published 2010
Oregon Health & Science University
..., and kidneys that leads to the production of biologically active agents, including angiotensin I and II...

17
by Norris, Susan L., Weinstein, Jessica, Peterson, Kim, Thakurta, Sujata
Published 2010
Oregon Health & Science University
..., and kidneys that leads to the production of biologically active agents, including angiotensin I and II...

18
by Nelson, Heidi D.
Published 2007
Oregon Health & Science University
... in menopausal women. Estrogen production declines in women when ovarian function changes with aging or after...

19
by Lee, Nancy J.
Published 2008
Oregon Health & Science University
... Administration, causing a black box warning to be placed in each product's labeling. Several pharmacokinetic...

20
by Lee, Nancy J.
Published 2008
Oregon Health & Science University
... Administration, causing a black box warning to be placed in each product's labeling. Several pharmacokinetic...